ADC Therapeutics SA
ADCT
$3.10
-$0.01-0.32%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 264.56M | 194.70M | 250.87M | 274.27M | 300.12M |
| Total Receivables | 26.18M | 31.76M | 20.32M | 24.03M | 22.87M |
| Inventory | 17.76M | 17.45M | 18.39M | 16.07M | 15.19M |
| Prepaid Expenses | 4.58M | 6.90M | 8.37M | 18.63M | 17.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.66M | 7.18M | 9.45M | -- | -- |
| Total Current Assets | 318.76M | 257.99M | 307.39M | 333.01M | 355.36M |
|
|
|||||
| Total Current Assets | 318.76M | 257.99M | 307.39M | 333.01M | 355.36M |
| Net Property, Plant & Equipment | 1.49M | 13.39M | 13.43M | 14.91M | 15.17M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.32M | 1.16M | 1.16M | 1.17M | 992.00K |
| Total Assets | 321.56M | 272.54M | 321.98M | 349.08M | 371.78M |
|
|
|||||
| Total Accounts Payable | 9.62M | 15.59M | 18.03M | 14.37M | 10.71M |
| Total Accrued Expenses | 42.67M | 31.42M | 49.82M | 40.07M | 34.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.79M | 1.37M | 1.37M | 8.70M | 1.42M |
| Total Finance Division Other Current Liabilities | 10.52M | 9.41M | 11.25M | 4.54M | 10.94M |
| Total Other Current Liabilities | 10.52M | 9.41M | 11.25M | 4.54M | 10.94M |
| Total Current Liabilities | 64.60M | 57.79M | 80.47M | 67.68M | 57.63M |
|
|
|||||
| Total Current Liabilities | 64.60M | 57.79M | 80.47M | 67.68M | 57.63M |
| Long-Term Debt | 447.72M | 440.62M | 433.73M | 436.81M | 429.88M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.26M | 7.91M | 8.00M | 8.88M | 9.31M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.17M | 4.45M | 2.43M | 7.65M | 6.62M |
| Total Liabilities | 520.75M | 510.76M | 524.62M | 521.03M | 503.45M |
|
|
|||||
| Common Stock & APIC | 1.39B | 1.29B | 1.29B | 1.29B | 1.29B |
| Retained Earnings | -1.59B | -1.53B | -1.49B | -1.46B | -1.42B |
| Treasury Stock & Other | -595.00K | -1.30M | -1.64M | -19.00K | -577.00K |
| Total Common Equity | -199.18M | -238.22M | -202.64M | -171.95M | -131.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -199.18M | -238.22M | -202.64M | -171.95M | -131.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -199.18M | -238.22M | -202.64M | -171.95M | -131.67M |
|
|
|||||